Evidence map›Paper›PMID 27012262›Full record

ReviewTranslational behavioral medicine2016

Financing prevention: opportunities for economic analysis across the translational research cycle.

D Max Crowley, Damon Jones

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Translational behavioral medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Integrating Retention Rates into Economic Analyses of Prevention Interventions.Prevention science : the official journal of the Society for Prevention Research · 2019
    Article
  2. Translating Prevention Research for Evidence-Based Policymaking: Results from the Research-to-Policy Collaboration Pilot.Prevention science : the official journal of the Society for Prevention Research · 2018
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

D Max CrowleyPennsylvania State University, University Park, PA, USA. MaxCrowley@gmail.com.ORCID http://orcid.org/0000-0001-8956-3456
Damon JonesPennsylvania State University, University Park, PA, USA.

Funding

Scientific Meetings for Advancing Economic Analyses of Substance Abuse PreventionR13DA036339 · NIDA · DUKE UNIVERSITY · PI DODGE, KENNETH A · 2014 to 2015
$38k
NIDA NIH HHS R13 DA036339
6 · The paper itself

Abstract

Prevention advocates often make the case that preventive intervention not only improves public health and welfare but also can save public resources. Increasingly, evidence-based policy efforts considering prevention are focusing on how programs can save taxpayer resources from reduced burden on health, criminal justice, and social service systems. Evidence of prevention's return has begun to draw substantial investments from the public and private sector. Yet, translating prevention effectiveness into economic impact requires specific economic analyses to be employed across the stages of translational research. This work discusses the role of economic analysis in prevention science and presents key translational research opportunities to meet growing demand for estimates of prevention's economic and fiscal impact.

Indexed as

Evidence-Based MedicineHumansPreventive Health ServicesTranslational Research, BiomedicalBenefit costEconomic evaluationPay for SuccessShadow prices

Identifiers

PMID27012262
PMCPMC4807188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.